TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
QGEN

Qiagen NV

Healthcare · Diagnostics & Research

44.40$ +3.4% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Qiagen NV (QGEN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.3% of the shares are freely tradable; institutional investors hold 83.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 83.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 99.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 4.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 207Mio.

Largest Shareholders

Institutions

Institutions QGEN
Name Stake (%) Shares Change (%) Date
Wellington Management Company LLP 6.01 12,406,763 -13.6 06/30/2026
T. Rowe Price Associates, Inc. 4.08 8,429,334 +5.3 03/31/2026
Principal Financial Group Inc 3.22 6,648,681 +120,281.7 06/30/2026
Vanguard Capital Management, LLC 2.96 6,106,275 +0.0 03/31/2026
Deutsche Bank AG 2.71 5,601,957 -25.4 03/31/2026
BlackRock Inc 2.54 5,250,461 +2.3 03/31/2026
Amundi 2.30 4,757,681 +18.3 03/31/2026

Funds

Funds QGEN
Name Stake (%) Shares Change (%) Date
Vanguard Health Care Inv 3.15 6,514,443 +0.0 06/30/2026
T. Rowe Price International Gr Eq Tr-D 2.60 5,376,369 +32.0 06/30/2026
MFS International Equity 2.11 4,363,511 -5.4 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?